SCHEMBL7757014

SCHEMBL7757014

O=C(Nc1ccc(O)c(Cl)c1)C(Cl)(Cl)Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
ALDH1A1 P00352 2/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
HTT P42858 2/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50
EPHX2 P34913 3/20 0.48
EPHX1 P07099 2/20 0.47
NR1H4 Q96RI1 1/20 0.44
MAOB P27338 2/20 0.44
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
HSD17B10 Q99714 1/20 0.43
CCR2 P41597 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6932087 0.85 EPHX1 (0.66) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL9402833 0.84 L3MBTL1 (0.60) MAPTALDH1A1LMNAHTTEPHX2
SCHEMBL8028212 0.82 KMT2A (0.44) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL4683057 0.79 MAPT (0.55) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL1943274 0.78 KDR (0.55) MAPTALDH1A1MEN1KMT2AHTT
SCHEMBL27280311 0.78 HSD17B10 (0.59) MAPTALDH1A1LMNAEPHX2EPHX1
SCHEMBL31198183 0.78 HSD17B10 (0.59) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL5674663 0.78 HSD17B10 (0.59) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL10877968 0.76 ALDH1A1 (0.46) MAPTALDH1A1MEN1KMT2AHTT
SCHEMBL7751082 0.75 GSTO1 (0.56) MAPTALDH1A1LMNAHTTEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0704539-B1 Chemiluminescent reagent and assay using a substituted acetanilide for light generation JOHNSON & JOHNSON CLIN DIAG (US) 2001-02-28 EP disclosed
EP-0603954-B1 Immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer JOHNSON & JOHNSON CLIN DIAG (US) 2000-03-08 EP disclosed
EP-0603953-B1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods JOHNSON & JOHNSON CLIN DIAG (US) 1999-02-17 EP disclosed
US-5736335-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1998-04-07 US disclosed
US-5705357-A DETECTING PEROXIDASE; SENSITIVITY, LOW BACKGROUND; MEDICAL DIAGNOSIS JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1998-01-06 US disclosed
US-5641635-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1997-06-24 US disclosed
EP-0704539-A2 Chemiluminescent reagent and assay using a substituted acetanilide for light generation JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) 1996-04-03 EP disclosed
US-5372931-A Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
US-5372932-A Peroxidase-labeled immunoreactant; stabiliztion with a 4-hydroxy or 4-alkoxyarylacetamide EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
EP-0603953-A1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed
EP-0603954-A2 Analytical element and immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed